O'Keefe James H, Abuissa Hussam, Sastre Antonio, Steinhaus David M, Harris William S
Mid America Heart Institute, Saint Luke's Hospital, Kansas City, Missouri, USA.
Am J Cardiol. 2006 Apr 15;97(8):1127-30. doi: 10.1016/j.amjcard.2005.11.025. Epub 2006 Mar 3.
We explored possible mechanisms by which recommended intakes of omega-3 fatty acids may decrease the risk for sudden cardiac death in patients with documented coronary heart disease. The cardioprotective effects of omega-3 fatty acids have been documented in epidemiologic and randomized controlled trials. These fatty acids are presumed to decrease susceptibility to fatal arrhythmias, but whether this is mediated by classic risk factors or direct cardiac mechanisms is not known. Eighteen white men with a history of myocardial infarction and ejection fractions <40% were randomized to placebo or omega-3 fatty acids (585 mg of docosahexaenoic acid and 225 mg of eicosapentaenoic acid) for two 4-month periods in a crossover design. At the end of each period, heart rate (HR), HR variability, and rate of HR recovery after exercise were determined, as were effects on arterial compliance, blood pressure, cardiac function, and fasting serum levels of lipids and inflammatory markers. Omega-3 fatty acids decreased HR at rest from 73 +/- 13 to 68 +/- 13 beats/min (p <0.0001) and improved 1-minute HR recovery after exercise (-27 +/- 10 to -32 +/- 12 beats/min, p <0.01). HR variability in the high-frequency band increased (p <0.02), but no change was noted in overall HR variability. There were no significant effects on blood pressure, arterial compliance, lipids, or inflammatory markers. These changes are consistent with an increase in vagal activity and may in part explain the observed decrease in risk for sudden cardiac death seen with omega-3 fatty acid supplementation.
我们探讨了推荐摄入量的ω-3脂肪酸可能降低已确诊冠心病患者心源性猝死风险的潜在机制。ω-3脂肪酸的心脏保护作用已在流行病学和随机对照试验中得到证实。这些脂肪酸被认为可降低致命性心律失常的易感性,但尚不清楚这是由经典危险因素介导还是由直接的心脏机制介导。18名有心肌梗死病史且射血分数<40%的白人男性,采用交叉设计,随机分为安慰剂组或ω-3脂肪酸组(585毫克二十二碳六烯酸和225毫克二十碳五烯酸),为期两个4个月周期。在每个周期结束时,测定心率(HR)、HR变异性以及运动后HR恢复率,同时测定其对动脉顺应性、血压、心脏功能以及空腹血脂和炎症标志物水平的影响。ω-3脂肪酸使静息心率从73±13次/分钟降至68±13次/分钟(p<0.0001),并改善了运动后1分钟的HR恢复(从-27±10次/分钟降至-32±12次/分钟,p<0.01)。高频带的HR变异性增加(p<0.02),但总体HR变异性未见变化。对血压、动脉顺应性、血脂或炎症标志物无显著影响。这些变化与迷走神经活动增加一致,可能部分解释了补充ω-3脂肪酸后观察到的心源性猝死风险降低。